Technology One ASX halt after cyber attack
Business software company Technology One has entered a trading halt after detecting a cyber hack. Read that and more tech news here.
Business software company Technology One has entered a trading halt after detecting a cyber hack. Read that and more tech news here.
The crypto world is once again feeling the pressure as it awaits the US Consumer Price Index. But Solana is celebrating a return to the top 10.
Creso Pharma’s wholly owned US subsidiary, Sierra Sage Herbs, has expanded its partnership with global e-commerce marketplace Groupon.
Portfolio manager Richard Ivers says the ASX small industrials sector’s lacklustre performance has left quality stocks at ‘very attractive valuations’.
Canaccord Genuity says the lithium market has bottomed out – and it sees upside of as much as 384 per cent in these five ASX stocks.
Despite a sharp price increase on Monday, investors have been urged to be careful before getting caught up in a rush back to iron ore.
Infinity continues to progress its San José lithium project in Spain with the receipt of the government’s response to its environmental impact assessment scoping document.
It’s been lean pickings for those seeking IPOs this year, but the ASX’s GM of listings is expecting a much more impressive second half.
Gold-rich South Australia seems on the cusp of a resources and mining bonanza, with the industry tipping almost $11 billion into the state’s economy.
With the Federal budget imminent, tech and finance CEOs are hoping The Treasurer’s wearing his Santa hat, writes Jeremy Liddle.
It’s hard to see what Flight Centre can do to end its reign as the ASX’s most shorted stock, with a huge lift this year clearly not enough.
Creso Pharma’s deal to acquire Health House International will give it a new revenue source, plus a way to import and distribute medicines containing psilocybin and MDMA.
A leading military supplier has given an insight into what Australia’s defence review means to ASX stocks – and a glimpse of some of the tech involved.
As Chinese consumers emerge from Covid cocoons with wellness front of mind, these ASX stocks are looking to get a slice of the action.
ASX stock Little Green Pharma has received a vote of confidence from French authorities after a stunningly positive cannabis trial.
Frog coin PEPE has gone ahead in leaps and bounds lately but is now chilling out. Meanwhile, Bitcoin transactions have gone nuts, forcing up fees.
As a junior stock, you know you’re doing well when big players start to take notice. That’s what’s happened to this lithium play, says Barry FitzGerald.
With fuel firms pumping up their service station stables despite a looming EV transition, a takeover target may have shown the way forward, says Tim Boreham.
Red Leaf Securities CEO John Athanasiou expects the tech sector recovery to keep gaining momentum. And these three stocks have caught his attention.
These ASX stocks with Canadian uranium projects can see happy times ahead, with prices tipped to rise, and big opportunities on the horizon.
US Fed boss Jerome Powell has delivered an unexciting update – which excited the crypto market a tad. But recent arrival Sui didn’t share the sentiment.
Caspin Resources’ share price skyrocketed after a ‘sensational’ find – but its rise pales into insignificance next to another miner’s 215 per cent two-day gain.
Small cap companies – and investors – are paying a high price for the lack of women in leadership roles, says Third Hemisphere MD Hannah Moreno.
Wesfarmers boss Robert Scott has sold $9 million of stock to pay tax, while Nickel Industries MD Justin Werner has splurged $1.9 million on shares.
Coal may leave those concerned about global warming cold, but it’s still warming the hearts of investors, says Tim Boreham.
ANZ expects gold to hit $US2080/oz in the next 12 months, and says the next big moves hinges on the US Federal Reserve’s interest rate decisions.
Bitcoin and crypto continue their game of snakes and ladders, with BTC plunging after a cascade of long-trading position liquidations.
Two recent ASX entries have been smash hits, even with the global IPO market struggling this year, and there are some other potential stars on the way.
The combination of US combat sports giants UFC and WWE offers opportunities for Aussie investors. Here’s how to kick things off.
While our nation deals with an unattractive economic outlook, Aussies are spending plenty on looking good. And these stocks are dazzling.
Gold producer Perseus Mining is undaunted by civil strife in Sudan and its attendant security concerns, as it eyes more African operations.
Two things to warm the hearts of crypto fans – Bitcoin regaining $US30,000 and tormentor-general SEC boss Gary Gensler being roasted by the US congress.
Pilot Energy continues to attract significant partners to its Cliff Head Carbon Capture and Storage Project in WA’s Mid West, with Svante Technologies the latest.
Helium production could be on the horizon for Blue Star after it received the green light to drill the first two development wells at Colorado’s high-grade Voyager project.
Godolphin has defined a maiden JORC 2012 resource of 94.9Mt at 739ppm TREO for Narraburra, which highlights its potential to be a significant rare earths project.
Control Bionics has unveiled its newest world-class technology offering for the global disability market – the first autonomous driving wheelchair module.
Creso Pharma’s strategy to drive revenue growth with a similar focus on cost management has been vindicated by cannabis division Mernova’s strong Q1 performance.
Tin is suddenly in the spotlight after a price surge of more than 10 per cent. But the lift comes amid warnings that the supply outlook for the vital metal is grim.
Artificial intelligence is on the march but financial advisers need not worry about being replaced in the forseeable future, experts say. Here’s why.
The Australian ETF industry is looking every bit the winner, after it rode global sharemarket gains to set a record for funds under management.
The US Security and Exchange Commission continues to clown around with crypto, this time suing Seattle-based exchange Bittrex. Meanwhile BTC battles on.
ASX stock Neuren Pharma has jumped nearly 6 per cent on news that its Rett syndrome drug is now available in the US, with big cash returns on the way.
Global training provider Site Group has signed up an additional 100 apprentices to its Maharat Construction Training Centre (MCTC).
Experts say we need to massively boost nickel supplies. So it’s no surprise ASX companies – including two newcomers – are heading to ‘elephant country’.
Funds manager Argonaut has taken a shine to two gold stocks and a lithium play, while Ord Minnett is eyeing Camplify as a good defensive stock.
The artificial intelligence sector is set to be worth $1.6 trillion by 2030. So how do you get a taste of the action? We consulted ChatGPT and real-life experts.
It’s not just property owners who are eagerly awaiting an end to Reserve Bank rate hikes. Lower rates will be a game-changer for non-bank lenders too.
There’s plenty of hopium around on Monday, with Bitcoin and Ethereum settling in at healthy prices and several altcoins looking ready for action.
Australia has more than 100 hydrogen projects worth up to $300 billion in the pipeline – but must get a move on if it wants to ride the wave, a new report says.
A company to join the ASX through an IPO next month will dominate ferrotungsten production outside of China and Russia – thanks to modern-day ‘alchemists’.
Original URL: https://www.heraldsun.com.au/business/stockhead/page/67